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Abstract While the commensal bacterium Propionibacterium acnes (P. acnes) is involved in the maintenance of a 
healthy skin, it can also act as an opportunistic pathogen in acne vulgaris. The latest ﬁndings on P. acnes shed light on 
the critical role of a tight equilibrium between members of its phylotypes and within the skin microbiota in the develop-
ment of this skin disease. Indeed, contrary to what was previously thought, proliferation of P. acnes is not the trigger of 
acne as patients with acne do not harbour more P. acnes in follicles than normal individuals. Instead, the loss of the skin 
microbial diversity together with the activation of the innate immunity might lead to this chronic inﬂammatory condition. 
This review provides results of the most recent biochemical and genomic investigations that led to the new taxonomic 
classiﬁcation of P. acnes renamed Cutibacterium acnes (C. acnes), and to the better characterisation of its phylogenetic 
cluster groups. Moreover, the latest data on the role of C. acnes and its different phylotypes in acne are presented, pro-
viding an overview of the factors that could participate in the virulence and in the antimicrobial resistance of acne-asso-
ciated strains. Overall, this emerging key information offers new perspectives in the treatment of acne, with future 
innovative strategies focusing on C. acnes bioﬁlms and/or on its acne-associated phylotypes.
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Colonisation of the pilosebaceous follicle by P. acnes is con-
sidered as one of the central factors driving acne by taking part
in the inflammatory response of the skin, in addition to the
cutaneous microbiota and innate immunity. Two other factors
involved in this chronic inflammatory skin disease are the
increased sebum production, with a modification of its composi-
tion, and hypercornification of the pilosebaceous follicle result-
ing from hyperproliferation and abnormal differentiation of
keratinocytes of the upper part of the follicle.7,8 There are many
other contributing factors that influence the severity as well as
the incidence and persistence of acne, such as environmental fac-
tors, hormones, family history and stress.8,9
Genomic and metagenomic investigations recently led both to
changing the denomination of P. acnes to Cutibacterium acnes
(C. acnes)10 accounting for its specific features to colonise the
skin, and to starting the characterisation of its different
Introduction
On the skin surface, the microbial community is mostly consti-
tuted by bacteria belonging to the three main genera of
Corynebacteria, Propionibacteria and Staphylococci.1 Interplay 
between members of this cutaneous microbiota is essential for
the maintenance of a healthy skin. While the commensal bac-
terium Propionibacterium acnes (P. acnes), predominant in seba-
ceous sites, is critical in the regulation of skin homeostasis2 and 
prevents colonisation from other harmful pathogens,3,4 it can 
also act as an opportunistic pathogen in acne vulgaris. New find-
ings on P. acnes reveal that, contrary to what was previously
thought, its proliferation is not the trigger of acne but instead, a
tight equilibrium between members of the skin flora and among
P. acnes phylotypes might play a more critical role in acne
onset.4,5 Loss of microbial diversity can indeed lead to chronic
inflammatory skin diseases.4,6
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genes content, clarified the phylogeny of the Propionibacteriaceae
family, in an attempt to better understand how species relate to
each other and unravel adaptive processes behind the transmis-
sion and evolutionary adaptation of P. acnes to human skin.10
This work led to the definition of a new genus for cutaneous
bacteria, the genus Cutibacterium gen. nov., which accommo-
dates the former cutaneous species.10 Notably, specific genes
were identified in these cutaneous species, especially lipase genes
encoding for triacylglycerol lipase and lysophospholipase able to
specifically degrade sebum lipids, while others disappeared by
deletions as part of the evolutionary adaptation of cutaneous
Propionibacterium to human skin. A taxonomic reclassification
was therefore proposed in which Propionibacterium acnes was
renamed C. acnes to account for all those genomic adaptive
changes and differentiate it from other environmental Propioni-
bacteria species, including those present in dairy products and
cattle rumen.10 This new denomination is used throughout this
review regardless of the species name in the original articles ref-
erenced.
Reﬁnement of C. acnes phylotypes with genomic
approaches
At the era of genomic research, various DNA-based methods
used for bacterial typing allowed the identification of distinct
C. acnes phylogenic groups but also yielded diverse nomencla-
tures that could be confusing. Hence for a better understanding,
we have established a summary table (Table 1) of typing meth-
ods and correspondences between initially defined phylotypes,
clonal complexes (CC), single-locus sequence typing (SLST)
types and ribotype denominations, based on the original publi-
cations and on the recent reviews of Yu et al.16 and McDowell.17
Initial genomic analyses used sequence comparison of either
recA or tly genes (the putative hemolysin gene) to categorise
C. acnes strains into phylotypes IA, IB, II and III.18–20 More reli-
able but time-consuming molecular typing methods, with a bet-
ter reproducibility and a high discriminatory power, were later
used to further discriminate C. acnes strains. Multi-locus
sequence typing (MLST) approaches, based on nine,21 then on
eight22 housekeeping genes, similarly identified the 3 divisions
(I, II and III) and further divided the type I strain into I-1a, I-1b
and I-221 or IA1, IA2, IB and IC
22 groups, each subtype also con-
sisting of distinct CC or singletons (Table 1). However, these
two classifications have created confusion. Afterwards and with
the aim to reduce time and cost, McDowell et al.23 described a
4-locus MLST (MLST4) method based on the MLST8 scheme,
that correctly predicted the six main phylogroups. An alternative
approach was also reported by Fitz-Gibbon et al.24 with the dis-
tinction of 10 major ribotypes using 16S rRNA gene ribotyping.
This method is cheaper but has a limited resolution and poorly
discriminates the major clusters of C. acnes (for example, RT1
and RT5 are present across different clades, see Table 1). As a
result, it is rarely used in clinical studies. Meanwhile, Nagy
phylotypes. Considering the potential central role of P. acnes/
C. acnes in acne, emerging key elements related to its genomic 
and phenotypic heterogeneity open the way to deeply explore 
the role of its different phylotypes in acne development, and give 
new insights on the cellular physiology underlying this patho-
genesis.
Therefore, this review aims to provide the most recent data 
re-evaluating the role of P. acnes/C. acnes and its different phylo-
types in acne. The phylogenetically distinct cluster groups of 
P. acnes/C. acnes, identified thanks to DNA-based typing meth-
ods, are first presented along with their new taxonomic classifica-
tions. On these bases, differences in phylotypes between healthy 
volunteers and individuals with acne are detailed, leading to the 
description of specific factors that may participate in the viru-
lence and in the antimicrobial resistance of acne-associated 
strains. Altogether, these data open new perspectives in acne pre-
vention and therapeutic approaches, involving adjunctive treat-
ments, via effects on skin microbiota or biofilm formation.
New data on C. acnes taxonomy
Among the multiple commensal microorganisms present in the 
healthy skin flora, P. acnes/C. acnes is a ubiquitous gram-
positive anaerobic bacterium belonging to the Actinobacteria 
phylum, that predominantly resides deep within the sebaceous 
follicle in contact with keratinocytes.3 Conversely, at the skin 
surface Propionibacteria are less represented (<2% of all bacte-
ria), in favour of Staphylococci, especially Staphylococcus epider-
midis (S. epidermidis), which dominate with >27% of the total 
bacteria population.11 P. acnes/C. acnes is also found in other 
tissues such as intestine, stomach, lungs, mouth, conjunctiva, 
prostate and urinary tract.3,12–14 Specific metabolic features 
allow P. acnes/C. acnes to colonise the hostile lipid-rich seba-
ceous follicle environment and protect skin from other harmful 
pathogens to preserve the stability of resident skin microbiota.3,4 
In particular, it can degrade triglycerides present in sebum to 
generate short-chain fatty acids, including propionic acid, which 
accumulation participates in the maintenance of an acid skin 
pH. Despite active research as P. acnes/C. acnes has been 
hypothesised as an important pathogenic factor in acne,15 its 
contribution to acne pathophysiology is not clearly established 
while its protective role as a commensal bacterium of healthy 
skin microbiota has been confirmed.3 Close examination of the 
skin microbiome using new genomic and metagenomic 
approaches is therefore instrumental to appreciate the diversity 
of the P. acnes/C. acnes population and begin to explore how 
this seemingly harmless bacterium might after all have a patho-
genic effect contributing to the development of acne lesions.
Reclassiﬁcation of Propionibacterium acnes as 
Cutibacterium acnes
Recently, a high-resolution core genome analysis combining 16S 
rRNA gene sequences, DNA G+C content, genome size and
presented in Table 1. Nevertheless, to facilitate comprehension,
a harmonised denomination of phylotypes based on the initial
phylotyping (IA1, IA2, IB, II and III) is used in the rest of the
review.
C. acnes phylotypes in acne
Skin with acne does not harbour more C. acnes than
normal skin
Recent evidence generated by sophisticated genomic techniques
and/or new sampling methods allowed it to be proved that, in
contrast to what has long been thought, C. acnes is by far the
most abundant and predominant bacterium in the microbiota
of pilosebaceous follicles both in acne patients and in individuals
with unaffected skin. Analyses indeed showed that the load of
C. acnes (this issue) or the relative abundance of C. acnes (in
metagenomics studies) is similar among patients with acne and
healthy individuals (87%–89%),24 or even slightly higher in
healthy subjects (89% vs. 94%).5 While there was no quantitative
difference of C. acnes between subjects with and without acne,
its phylogenic groups displayed specific genetic (see the follow-
ing article in this issue) and phenotypic characteristics. Thus, it
was hypothesised that some strains may be truly commensal and
Table 1 Summary of nomenclatures of C. acnes phylotypes obtained with the main described typing methods and corresponding clonal
complexes, types or ribotypes
Typing based on tly
and recA genes
MLST9†
(145 ST)‡‡
Aarhus scheme
eMLST8‡
(138 ST)‡‡
Belfast scheme
SLST§
(113 types)‡‡
Mass spectrometry
typing¶
Ribotyping††
IA1 I-1a CC18 IA1 CC-1 A1-34 IA IA-1 RT5
Singletons B1 RT1
RT532
CC3 CC-3 C1-5 IA-2 RT4
Singleton RT1
CC28 D1-5 RT5
CC31 CC-4 E1-9 IB-1 RT8
IA2 I-1b CC28 IA2 CC-2 F1-14 IA IB-2 RT3
Singleton Singletons RT16
IB I-2 CC36 IB CC-5 H1-8 IB IB-3 RT1
Singleton
NA NA Singletons IC CC-107 G1 IB/(IC) IC RT5
II II CC53 II CC-6 K1-25 II II RT2
CC60 CC-72 RT6
Singleton Singletons RT1
III NA CC43 III CC-77 L1-10 III RT9
Singletons Singleton III/1 NA
Sources: Yu et al.,16 McDowell et al.,27 McDowell et al.17 and †Lomholt and Kilian,21 ‡McDowell et al.,22 §Scholz et al.,26 ¶Nagy et al.,25 ††Fitz-Gibbon
et al.,24 Tomida et al.31
‡‡Last update January 15th 2018.
Note that the Aarhus scheme detects CC28 in IA1 and IA2 clades.
CC, clonal complex; MLST, multilocus sequence typing; NA, not assessed; RT, ribotype; SLST, single locus sequence typing; ST, sequence type.
et al.25 designed a rapid mass spectrometry assay to identify the 
major phylotypes without using PCR. Even though phylotypes 
IA1 and IA2 cannot be distinguished, this method correctly 
identifies phylotypes IA, IB, II and III as well as a new III/1 phy-
lotype (Table 1). More recently, a SLST scheme was proposed, 
that has a resolution comparable to that of existing MLST 
schemes but, contrary to them it can be used for mapping of 
multiple strains in a complex microbial environment.26 In this 
work, phylogenetic analysis of the 41 distinct SLST types (A1 to 
L1), identified among 187 strains previously typed with MLST9, 
demonstrated the overall congruency between both typing meth-
ods. These genomic investigations, together with morphological 
and biochemical approaches, allowed better comparison of 
C. acnes strains belonging to the three main phylotypes (I, II 
and III), leading to the recent proposal of their reclassification in 
distinct subspecies: phylotype I as C. acnes subsp. acnes,10 phylo-
type II as C. acnes subsp. defendens27 and phylotype III as C. ac-
nes subsp. elongatum.28
Altogether, these studies using various DNA-based techniques 
assessed the great diversity and complexity of C. acnes popula-
tion and prompted rapid progress in the characterisation of its 
main phylotypes. As most typing methods are still in use today, 
despite all of their advantages and drawbacks, they are all
Unique genomic elements seem to be associated with
acne
At the molecular level, lineage-specific genetic elements have
been identified among 82 C. acnes strains isolated from acne or
healthy skin.31 These specific loci may explain the phenotypic
and functional differences of C. acnes phylotypes as a commen-
sal in health and as a pathogen in diseases. For instance, three
genomic loci, which were unique to phylotype IA1, encode sev-
eral virulent genes and may thus contribute to virulence of these
mainly acne-associated strains. Vice versa, the distinctive geno-
mic characteristic of phylotype II, enriched in healthy skin, is the
clustered regularly interspaced short palindromic repeats
(CRISPR)/Cas locus considered as an adaptive immune system
for bacteria that may allow the elimination of invasive foreign
DNA, hence preventing the acquisition of virulent genes. Thus,
in the phylotype I strains, mainly involved in acne lesions, the
deletion of this CRISPR/cas locus may account for their ability
to horizontally acquire fitness or virulence traits.37 Moreover,
deletions in the regulatory regions of a lipase gene in phylotype
II strains may potentially explain their decreased lipase activity
and their decreased virulence in acne.31
In the same way, in-depth metagenomic analysis of the whole
skin microbial community, including the comparison of specific
C. acnes operational gene groups, showed a strong enrichment
in a variety of virulence-related genes and reduced abundance in
metabolic synthesis genes in patients with acne compared with
healthy subjects.5 Following this work, a robust set of differen-
tially abundant metagenomic elements was identified and could
be used as markers for classification of the clinical states of the
skin and finally to detect balance shifts towards acne.
C. acnes phylotypes and acne severity
A recent pilot observational study looking at the possible link
between acne severity and a specific C. acnes subtype or subpop-
ulation in the lesions, found no difference in the distribution of
phylotypes between patients with mild acne and those with sev-
ere acne, even though phylotype IA1 was the most represented
in both populations.36 A Japanese study, using the same SLST
method, also showed that phylotype IA1 was predominant in
each acne severity category (with 60%, 57.1% and 63.3% of
strains in the severe, moderate and mild acne groups, respec-
tively). In contrast, phylotype IA2, highly resistant to clin-
damycin, seemed to be more frequently associated with severe
and moderate acne, which was hypothesised to aggravate acne
severity.38 Overall, these divergent findings highlighted that the
severity of acne might not only be due to a specific C. acnes
strain but also to host and environmental factors that could
potentially yield different level of activation of innate immunity
in severe acne.36 Early and intense inflammatory events in the
epidermis have indeed been shown to contribute to the develop-
ment of scars.39
contribute to skin health, whereas others may have the potential 
to act as opportunistic pathogens. To confirm this assumption, 
distribution patterns of C. acnes population have been investi-
gated in acne pathology at the strain and genetic levels, both at 
the skin surface and in acne lesions.
Speciﬁc C. acnes strains are associated with acne
In a study of 2010, Lomholt and Kilian21 observed that among a 
great number of C. acnes isolates (N = 210) from skin of healthy 
individuals, and patients with varying degrees of acne, or other 
infectious diseases, those from division IA were strongly associ-
ated with moderate to severe acne while others, IB, II and III, 
were associated with healthy skin and opportunistic deep tissue 
infections. These first observations were further confirmed by 
another group using the eMLST8 method, showing that phylo-
type IA1 was predominantly associated with acne, while phylo-
type IA2, IB and II isolates were less represented in this skin 
condition.22,23 Based on PCR using type-specific primers of phy-
lotypes IA, IB and II, Kwon et al.29 found that phylotypes distri-
bution was similar between skin surface and comedones lesions, 
but papules and pustules were characterised by an increase in 
phylotype IA and a decrease in phylotypes IB and II. This obser-
vation suggested that phylotype IA preferentially proliferate in 
an inflammatory microenvironment, therefore indicating a shift 
in the skin microbiota of acne patients. A more comprehensive 
sampling technique and a metagenomic analysis using ribotyp-
ing confirmed that the strain population structures were signifi-
cantly different between skin microcomedones from acne 
patients and healthy individuals: phylotype IA1 was more 
strongly associated with acne, while phylotype II was preferen-
tially present in skin from healthy subjects and other ribotypes 
belonging to various phylotypes (IA, IB and II), exhibited a uni-
form dispersion across both cohorts.24 A recent study provided a 
more detailed landscape of the clonal complexity and dominant 
clones in follicles from patients with moderate to severe acne, 
using the Aarhus scheme (MLST9, Table 1).30 The C. acnes phy-
lotype IA1 was the dominant follicular type in Caucasian 
patients with acne, while clones from healthy subjects were more 
heterogeneous with strains from various phylotypes, IA1, IA2, IB 
and II. However, the phylotype IA1 isolates did not exhibit dif-
ferences in gene content or genetic elements between healthy 
controls and acne patients that could explain its association with 
the disease status.30 Indeed, the gene synteny is remarkably con-
served, indicative of a highly stable C. acnes chromosome, the 
core genome representing 88% of the average genome.31 Regard-
ing the phylotype III, its possible involvement in C. acnes deep 
tissue infections along with the phylotype IB,23,32–34 and other 
pathologies5,33,35 was recently considered, and it was even 
detected in patients with severe acne (36 and this issue). Never-
theless, it was never predominant and not frequently associated 
with this skin disease.
CAMP factors and the association of specific C. acnes strains
with acne.
Porphyrins
Porphyrins, which exhibit absorbance properties in ultraviolet
and visible light, are produced by C. acnes and might contribute
to the perifollicular inflammatory reaction during acne develop-
ment. Indeed, their ability to generate singlet oxygen from oxy-
gen under ultraviolet exposure might enhance the production of
cytotoxic substances by oxidation processes, such as squalene
peroxide, a proinflammatory lipid.47 Moreover, they can stimu-
late the expression of keratinocyte-derived interleukin (IL)-8
and prostaglandin E2 that are mediators of inflammatory and
immune responses.47,48 Interestingly, phylotype IA1 strains iso-
lated from patients with acne were found to produce signifi-
cantly higher levels of porphyrins than healthy skin-associated
phylotype II strains.49 This finding was correlated with the pres-
ence of a repressor gene (deoR) of porphyrin biosynthesis in all
phylotype II strains, but not in IA1 strains.
Hyaluronate lyase
Recently, another putative virulence factor, the hyaluronate lyase
(HYL), has been reported with different gene alleles depending
on C. acnes phylotypes.34,50 A genotypic and phenotypic investi-
gation, including the generation of a C. acnes hyl knockout
mutant, revealed two distinct variants of HYL: one highly active
variant (HYL-IB/II), resulting in complete hyaluronic acid
degradation and another variant with low activity (HYL-IA),
resulting in incomplete hyaluronic acid degradation.51 Hyaluro-
nate lyase, along with other enzymes capable of destroying com-
ponents of the dermal and epidermal extracellular matrix, such
as proteins, hyaluronic acid and other glycosaminoglycans, may
indeed promote the spread of inflammation during acne devel-
opment.
Other virulence factors
The acne-associated phylotype IA1 also contains a novel plasmid
with a tight adhesion locus and two unique genomic islands, that
comprise genes supposed to enhance virulence through
increased bacterial adhesion and host immune response.24 In
addition, a correlation between the severity of acne and lipase
activity has been shown with the C. acnes phylotype I that pro-
duces higher quantities of propionic and butyric acids than
other C. acnes biotypes and that predominates in isolates from
most severe acne skins.43,52 These isolates might thus have the
greatest influence on skin rash in acne patients. Nevertheless, a
recent proteome analysis of human sebaceous follicle infundi-
bula extracted from healthy and acne-affected skin revealed at
least 12 putative lipases, but only two (GehA and GehB) possess
a signal peptide for secretion.45 GehB was mainly associated with
healthy skin, with more diverse C. acnes community population,
suggesting a beneficial effect of this lipase. However, it is possible
Despite some heterogeneities between studies, regarding pop-
ulation samplings, anatomic sites and typing methods, those 
results suggest that some C. acnes phylotypes IA preferentially 
colonise skin with acne while others are not or poorly present in 
acne lesions (IB, II and III). However, quantitative analyses are 
not always reliable as skin sampling methods are very heteroge-
neous between studies and not all of them are sensitive and 
accurate, making result comparison across studies quite diffi-
cult.40,41
C. acnes phylotypes and virulence
Phylogenic studies also showed that acquired DNA sequences 
and bacterial immune elements may have roles in determining 
virulence properties of C. acnes strains. Moreover, biochemical, 
transcriptomic and proteomic analyses demonstrated that C. ac-
nes phylotypes exhibit differences in inflammatory potential and 
expression of various putative virulence factors that may explain 
their distinct involvement in acne disease.40,42 These factors 
include neuraminidase, lipase, polyunsaturated fatty acid iso-
merase, the iron acquisition protein HtaA (a highly immunore-
active cell surface antigen) and heat shock proteins (HSP20, 
DnaK, DnaJ, GrpE and GroEL).3 Host-interacting factors, such 
as CAMP factors, hemolysins and dermatan sulphate-binding 
adhesins (DsA1 and DsA2) have also been identified as possible 
pathogenic factors.3,40 Some of them might constitute future tar-
gets for therapeutic interventions and are thus further described.
CAMP factors
The five CAMP factors, encoded by the genome of all C. acnes 
strains, are membrane pore-forming toxins that act as host tissue 
degradation enzymes. These secretory proteins are potentially 
cytotoxic for keratinocytes and macrophages and their activation 
may result in skin inflammation.43 Recent in vitro findings indi-
cated that CAMP1 may be involved in C. acnes virulence by 
interacting directly with TLR2, thus amplifying the inflamma-
tory response.44 More specifically, CAMP1-TLR2 binding inten-
sity was stronger in phylotype IB and II strains than in 
phylotype IA1 and IA2 strains, which was respectively correlated 
with high and low production levels of the proinflammatory 
cytokine CXCL8. Consistently, CAMP1 factor genes were found 
to be most strongly expressed in types IB and II, while CAMP2 
factor was detected in greater amounts in IA isolates.19 However, 
it should be pointed out that in proteomic analyses, CAMP1, as 
well as adhesins, are the most abundant proteins of C. acnes in 
sebaceous follicle from both normal and acne skin.45 Moreover, 
by disrupting two of the five CAMP genes in a C. acnes isolate 
KPA171202 (IB strain), S€orensen et al.46 demonstrated that the 
Dcamp2 but not the Dcamp4 mutant exhibited reduced haemo-
lytic activity in the CAMP reaction with sheep erythrocytes, indi-
cating that CAMP2 is the major active co-haemolytic factor of 
C. acnes. These experimental researches remain exploratory and 
cannot yet confirm the relationship between the expression of
that other lipases, produced by different C. acnes phylotypes,
play distinctive roles in regard to health and disease, but this
hypothesis needs further investigations.
Overall, these factors may be important in the emerging asso-
ciation of some C. acnes strains with acne and participate in the
modulation of the cutaneous innate immunity and skin inflam-
mation that may influence the severity of inflammatory acne
lesions and scars.53,54
C. acnes phylotypes and inﬂammation
Additional proteins such as the thrombospondin type 3 and the
polycystic kidney disease may participate in C. acnes adhesive
properties in the biofilm.56
A biofilm is an organised conglomerate of bacterial cells
attached to a surface and embedded into a self-produced poly-
meric extracellular matrix composed of polysaccharides. This
complex protective shell forms a barrier allowing large clusters
of bacteria to survive in harsh environments. The ability of
C. acnes to form biofilms was originally described in 2007.57 Ses-
sile C. acnes cells that grow in biofilms are more resistant to tra-
ditional antimicrobial agents than planktonic (free) cells even if
the biofilm consists in antibiotic-sensitive strains58 and have a
greater extracellular lipase activity, implicated in inflamma-
tion.57 In 2012, a case–control pilot study performed on facial
skin biopsies reported for the first time that C. acnes can grow in
macrocolonies producing large biofilms deep within the pilose-
baceous follicles. They consisted of at least IA and II phylotypes
and contained secreted bacterial proteins with known
immunoreactive properties.59 Biofilm cells were indeed charac-
terised by up-regulated stress-induced genes and up-regulation
of genes encoding the potential virulence-associated CAMP fac-
tors.60 It is interesting that the occurrence of C. acnes biofilms
was significantly higher in patients with acne (37%) than in con-
trol subjects (13%).59 However, whereas phylotype IA strains
were shown to be mainly associated with acne in recent metage-
nomic studies, these large macrocolonies appeared to consist of
various C. acnes phylogroups (at least IA and II) coexisting
within the same follicle.59 These contradictory observations
make it difficult to associate either phylotype individually with
the acne aetiology. Furthermore, Holmberg et al.61 found that
C. acnes isolates from skin are less efficient in forming biofilms
than isolates from deep tissues infection. These blurry points
warrant clarification in future researches.
C. acnes response to antibiotics
Systemic and topical antibiotics have long been at the core of the
acne therapeutic arsenal. As commonly known, Propionibac-
terium species are naturally resistant to 5-nitroimidazole agents
(metronidazole, tinidazole and ornidazole), aminoglycosides,
sulfonamides and mupirocin and C. acnes is generally suscepti-
ble to a large variety of widely used antimicrobials. However,
resistance of C. acnes to antibiotic treatments has gradually
emerged over the years to become a worldwide problem, with
high rates of resistance reported for erythromycin (macrolides)
and clindamycin (lincosamides) (between 21% and 70%) and
less frequent resistances to tetracycline (between 4% and 30%),
in line with the most frequent use of topical macrolides.62–64
The most common mechanism of antibiotic resistance in
C. acnes is chromosomal point mutations, mainly in the 23S
rRNA gene for macrolides resistance and 16S rRNA gene for
tetracycline resistance.63,65 The acquired transposon carrying the
erm(X) gene, which encodes an rRNA methyltransferase, is also
A comparative proteomic analysis of six C. acnes isolates belong-
ing to all representative phylotypes (IA1, IA2, IB1, IB2, II and 
III), revealed a differential expression pattern of proteins 
between them.55 The most differently expressed proteins 
included adhesion proteins, CAMP factors, and one cell surface 
hydrolase. More specifically, the increased production of inflam-
matory IFN-c and IL-17 may be induced by acne-associated 
phylotypes suggesting that some strains might promote acne by 
activating both Th1 and Th17 responses.55 Concordantly, 
decreased levels of IL-10, that downregulates IFN-c and IL-17 
thereby reducing inflammation, were found with strains related 
to acne (IA1) and some strains considered as neutral (IB). How-
ever, the precise role of some of these newly identified and dif-
ferently expressed proteins in C. acnes phylotypes remains to be 
clarified in the process of skin inflammation and acne pathogen-
esis.
These data are however somewhat contradictory with the 
study of Jasson et al.53 showing that C. acnes phylotype III had a 
high pro-inflammatory potential by up-regulating the expression 
of PAR-2, TNF-a, MMP-13 and TIMP-2 in skin explants while, 
the IB phylogenetic cluster produced a minimal effect. These 
findings allowed the authors to propose a classification of the 5 
C. acnes phylotypes according to their proinflammatory poten-
tial, from the strongest to the mildest: type III, II, IC, IA1 and 
IB.53
Thus, phylogenetic cluster groups of C. acnes appear to pre-
sent various pathogenic characteristics, including distinct abili-
ties to elicit inflammation and secretome profiles that suggest an 
aetiological role of some particular strains in acne.24,30,55 Further 
investigations are needed although to get better insights on these 
strain-specific factors and their link with the inflammatory 
response but also with other cellular processes involved in acne 
progression, as mentioned in a recent review8 highlighting the 
interconnection between inflammation, lipid metabolism and 
innate immunity processes within the pilosebaceous duct.
Bioﬁlm formation
Besides virulence factors, several genes present on the C. acnes 
genome (encoding glycosyltransferase, uridine diphosphate-N-
acetylglucosamine 2-epimerase and polysaccharide biosynthesis 
proteins) are also potentially involved in the formation of bio-
film, which participates in the pathophysiology of acne.43
with various levels of resistance that can explain a limited over-
all response of a patient to conventional antibiotics.41,67
In addition to acquired resistance, bacterial biofilms might
also play a role in C. acnes reduced susceptibility to antibiother-
apy and increased resistance to phagocytosis. An intrinsic prop-
erty of bacteria in biofilms is indeed their increased tolerance to
antibiotics, even if the strains forming the biofilm are normally
sensitive to antibiotics (see the following article and58). Alto-
gether, resistance, virulence factors, restricted access to immune
defense cells of the host, poor penetration of antibacterial agents
and selection of ‘persister’ cells are among the mechanisms pro-
posed to explain increased tolerance to antibiotics in C. acnes
biofilms.60,63
Keeping in mind the emergence of acquired resistance of
C. acnes against the currently approved antibiotics,41,64 another
main concern for using antibiotics is the overall modification of
the human skin microbiome, where resistant bacterial species
may emerge via selective pressure.63 These growing threats
should thus conduce to a limited use of topical and systemic
antibiotics as long term and monotherapy regimens in acne and
to the use of alternative treatments, such as benzoyl peroxide
alone or combined with topical retinoids 64,70 according to inter-
national guidelines for treatment of acne71,72.
Conclusion and perspectives
To sum up, while C. acnes is present on the skin surface at a low
level, it is the dominant resident bacterial species in the seba-
ceous follicles. Contrary to what was previously thought, acne
vulgaris is not the result of a greater proliferation of all C. acnes
strains, as patients with acne do not harbour more C. acnes in
follicles than normal individuals. Instead, acne might be trig-
gered by the selection of a subset of C. acnes strains, including
the acne-associated phylotype IA1, probably enhanced by a
hyperseborrheic environment. Besides, biofilm formation and
differences in virulence and inflammatory potential of C. acnes
strains might enhance their pathogenicity. Specific operational
genomic sequences present in the whole skin microbiota, also
support the new paradigm that an equilibrium state exists within
the skin microbiota and between the different C. acnes subtypes.
Recent data show that S. epidermidis and C. acnes interact
together and are critical in the regulation of skin homeostasis.2,11
In particular, S. epidermidis is known to inhibit C. acnes
growth11,73,74 and C. acnes-induced inflammation75 in skin.
Changes in physiological conditions may lead to an imbalance
between the different skin community members, called
dysbiosis, and eventually to the selection of more pathogenic
C. acnes strains.4,42 Disruption of equilibrium within the skin
microbiota and intrinsic properties of C. acnes might therefore
be conducive to the activation of innate immunity, resulting in
cutaneous inflammation.
Overall, this review underscores the importance of C. acnes
phylotype IA1 in acne and suggests the implication of other
involved in clindamycin, erythromycin and telithromycin resis-
tance.66 At last, amino acid substitution in the ribosomal S10 
protein encoded by rpsJ gene also contributes to reduce doxycy-
cline susceptibility in C. acnes.38 Of notice, in Lomholt’s study, 
which examined C. acnes resistance in 350 isolates collected 
from various countries, tetracycline resistance was detected 
exclusively among isolates from Danish acne patients, who each 
carried 1–6 clones of C. acnes.67 This observation was correlated 
with the almost exclusive use of tetracycline for the treatment of 
acne in Danish primary health care suggesting that the pro-
longed or inappropriate use of antimicrobial agents can lead to 
the spread of resistance in C. acnes strains as well as among 
other members of skin microbiota.63 While the role of previous 
therapeutic interventions is relevant on C. acnes resistance in 
acne, especially for topical macrolides and lincosamides with 
more than 70% of patients carrying resistant C. acnes strains to 
erythromycin and clindamycin,64 many other factors might be 
implicated. Indeed, for quinolones, no correlation could be 
identified as no difference was detected in rate of levofloxacin 
resistance between severe and mild acne, despite orally adminis-
tered quinolones being more frequently prescribed for severe 
than mild acne.38
Literature regarding an association between strains of 
C. acnes and resistance to antibiotics is scarce. Nevertheless, 
concordant data demonstrated that phylotype IA1 strains, 
highly associated with acne, represented most erythromycin-
and clindamycin-resistant strains and to a lesser extent tetracy-
cline-resistant strains.22,67 Moreover, in McDowell’s study, all 
tested phylotype IC isolates (N = 4) were resistant to ery-
thromycin and tetracycline.22 Most of these resistant clones 
presented mutations in their 23S and 16S rRNA genes.22,24 The 
recent description of fluoroquinolone-resistant C. acnes strains 
in acne revealed phylotype IA as the predominant cluster.68 
Focusing on the molecular mechanism involved in this resis-
tance, the authors further demonstrated that most of the clini-
cal strains belonged to phylotype IA138. In a recent case 
report,69 bacterial isolates from a slow responder to antimicro-
bial treatments were found to be phylogenetically heteroge-
neous and presented variable resistance to clindamycin. In a 
surprising manner the pathogenic phylotype IA1 displayed clin-
damycin sensitivity, whereas phylotype IB, associated with com-
mensals, exhibited high clindamycin resistance. After a 
sensitivity analysis revealing susceptibility of C. acnes isolates to 
tetracycline and nadifloxacin, the authors switched the regimen 
to a combination of minocycline and nadifloxacin that signifi-
cantly improved the clinical lesions. This individual characteri-
sation of C. acnes isolates in acne lesions demonstrated the 
relevance of such a personalised approach to choose the best 
antibiotics but also suggested that the association of certain 
C. acnes phylotypes with acne may be more complex than 
anticipated. To complicate matters, at the lesion level each folli-
cle behaves independently and may contain a mixture of strains
members of the human cutaneous microbiome in this skin con-
dition. As a consequence, improved understanding of the genetic
and phenotypic diversity of C. acnes strains as well as the
involvement of other bacterial species, could be applied in the
development of alternative and personalised therapies addressing
the pathogenic strains only and leaving the commensal strains
intact.
For instance, small molecules, such as levulinic acid, able to
inhibit porphyrin biosynthesis in acne-associated C. acnes
strains without disrupting the growth of health-associated
strains, are attractive drug candidates for the treatment of
acne.49 Biofilms can also constitute novel targets to overcome
increased resistance to antibiotics and restore a balanced cuta-
neous microbiome. Interestingly, using anti-biofilm compounds
like Myrtacine, a natural active agent containing myrtucom-
mulones, can help to deconstruct the biofilm and restore antibi-
otic sensitivity even in resistant strains (58 and this issue). In the
same way, a topical gel containing salicylic acid and designed to
address C. acnes biofilm exhibited a positive effect on acne
lesions.76 Such products can thus constitute original antimicro-
bials that could be used as efficient adjunctive agents during the
antibiotic course for acne treatment. Recent findings on the bal-
ance of the skin microbiota also suggest potential future devel-
opment of individualised acne therapies and the maintenance of
skin health, by supplementing the skin microbiota with probi-
otics to shift the balance towards a healthy microbiome.5 Vari-
ous and novel treatment options, focusing on C. acnes biofilms
and/or on its acne-associated phylotypes, are hence worthy of
further exploration in clinical settings for acne management.
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